相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potential for modulation of platelet function via adenosine receptors during inflammation
Magdalena Boncler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2023)
Antioxidant Capacity and Antiplatelet Activity of Aqueous Extracts of Common Bean (Phaseolus vulgaris L.) Obtained with Microwave and Ultrasound Assisted Extraction
Lyanne Rodriguez et al.
PLANTS-BASEL (2022)
The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders
Anisa Degjoni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
PSB 603-a known selective adenosine A2B receptor antagonist - has anti-inflammatory activity in mice
Magdalena Kotanska et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Preparations from selected cucurbit vegetables as antiplatelet agents
Agata Rolnik et al.
SCIENTIFIC REPORTS (2021)
Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders
Lisa Repsold et al.
CELLS (2021)
Platelet inhibition by P2Y12 antagonists is potentiated by adenosine signalling activators
Chih-Chin Shih et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Inflammatory Mechanisms Contributing to Endothelial Dysfunction
Panagiotis Theofilis et al.
BIOMEDICINES (2021)
Platelet Purinergic Receptors in Thrombosis and Inflammation
Christian Gachet et al.
HAMOSTASEOLOGIE (2020)
8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A2A receptors. Design, synthesis and biological evaluation
Michal Zaluski et al.
BIOORGANIC CHEMISTRY (2020)
Critical roles of inflammation in atherosclerosis
Junji Moriya
JOURNAL OF CARDIOLOGY (2019)
A2B Adenosine Receptor Antagonists with Picomolar Potency
Jie Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Adenosine and the Cardiovascular System
Allison B. Reiss et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2019)
Adenosine and Forskolin Inhibit Platelet Aggregation by Collagen but not the Proximal Signalling Events
Joanne C. Clark et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients
Mohammed El Haouari
CURRENT MEDICINAL CHEMISTRY (2019)
Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy
Nina Wolska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Antiplatelet Activity of Natural Bioactive Extracts from Mango (Mangifera Indica L.) and its By-Products
Maria Elena Alanon et al.
ANTIOXIDANTS (2019)
Antithrombotic P2Y12 receptor antagonists: recent developments in drug-discovery
Younis Baqi et al.
DRUG DISCOVERY TODAY (2019)
Novel phosphodiesterases inhibitors from the group of purine-2,6-dione derivatives as potent modulators of airway smooth muscle cell remodelling
Katarzyna Wojcik-Pszczola et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Adenosine A2A receptor agonists with potent antiplatelet activity
Eduardo Fuentes et al.
PLATELETS (2018)
Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT2A and α2-adrenoceptor antagonistic properties. A comparison with ketanserin, sarpogrelate, prazosin, yohimbine and ARC239
Monika Kubacka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Research Progress on the Relationship between Atherosclerosis and Inflammation
Yuhua Zhu et al.
BIOMOLECULES (2018)
Platelet oxidative stress as a novel target of cardiovascular risk in frail older people
Francisco Fuentes et al.
VASCULAR PHARMACOLOGY (2017)
Doxepin inhibits GPVI-dependent platelet Ca2+ signaling and collagen-dependent thrombus formation
Sascha Geue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2017)
Ultra-pure platelet isolation from canine whole blood
Shauna A. Trichler et al.
BMC VETERINARY RESEARCH (2013)
Optimization of Multiplate® whole blood platelet aggregometry in the Beagle dog and Wistar rat for ex vivo drug toxicity testing
Myriam Defontis et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2013)
Anti-inflammatory effects of inosine in allergic lung inflammation in mice: evidence for the participation of adenosine A2A and A3 receptors
Fernanda da Rocha Lapa et al.
PURINERGIC SIGNALLING (2013)
Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y12 Antagonist
David Iyu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Anti-platelet therapy: phosphodiesterase inhibitors
Paolo Gresele et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones
Anna Drabczynska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Physiological Implications of Adenosine Receptor-Mediated Platelet Aggregation
Hillary A. Johnston-Cox et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Platelet receptor signaling in thrombus formation
David Stegner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
CalDAG-GEFI is at the nexus of calcium-dependent platelet activation
Lucia Stefanini et al.
BLOOD (2009)
1-Alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: Development and Characterization of Adenosine A2B Receptor Antagonists and a New Radioligand with Subnanomolar Affinity and Subtype Specificity
Thomas Borrmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Phosphodiesterases do not limit β1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats
Alberto J. Kaumann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Oxidative stress and platelets
Jane E. Freedman
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Blockade of adenosine A2B receptors ameliorates murine colitis
V. L. Kolachala et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Nonlinear model-based estimates of IC50 for studies involving continuous therapeutic dose-response data
Robert H. Lyles et al.
CONTEMPORARY CLINICAL TRIALS (2008)
Enfermedad aterotrombótica coronaria: avances en el tratamiento antiplaquetario
Lina Badimon et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2008)
The Adenosine A2b Receptor: Its Role in Inflammation
J. Ham et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
Platelet cyclic adenosine monophosphate phosphodiesterases: Targets for regulating platelet-related thrombosis
RW Colman
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets - In vitro and in vivo/ex vivo studies
B Aktas et al.
STROKE (2003)
New mechanism of action for cilostazol: Interplay between adenosine and cilostazol in inhibiting platelet activation
B Sun et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
The pharmacology of cilostazol
K Schror
DIABETES OBESITY & METABOLISM (2002)
Coronary disease - The pathophysiology of acute coronary syndromes
MJ Davies
HEART (2000)
分享论文
